NCT02624115View on ClinicalTrials.gov

FAZA PET as Biomarker for Hypoxia in Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

June 9, 2019

Study Completion Date

June 9, 2019

Conditions
Colon Rectal Cancer Adenocarcinoma
Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02624115 - FAZA PET as Biomarker for Hypoxia in Rectal Cancer | Biotech Hunter | Biotech Hunter